Solid Biosciences (SLDB)

• Market cap: $503M
• 1 day: -2.12%
• 5 days: -0.62%
• 1 month: 13.33%
• 3 months: 21.66%
• 6 months: -8.63%
• Year to date: 18.53%
• 1 year: 94.58%
• 5 years: -93.36%
• 10 years: -98.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Employees: 100